Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001039980 | SCV001203532 | pathogenic | Hereditary breast ovarian cancer syndrome | 2020-08-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asp1739Valfs*26) in the BRCA1 gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in BRCA1 are known to be pathogenic (PMID: 20104584). This variant has not been reported in the literature in individuals with BRCA1-related conditions. This variant is not present in population databases (ExAC no frequency). |